The SMIM1 gene makes a small protein on red blood cells that forms the Vel blood group marker. If it does not work, a person is usually healthy but may have the rare Vel-negative blood type. This matters most during blood transfusion, because getting Vel-positive blood can trigger a strong immune reaction in someone who is Vel-negative. In medicine, this gene is important because it helps explain why careful blood matching is needed for some people.
What is a gene?
Genes are stretches of DNA that carry instructions your cells use to make molecules or regulate activities in the body. Some genes provide the directions for producing proteins, which are the working parts of cells. Other genes mostly help direct when certain processes happen, where they happen, and how strongly they take place. Together, genes affect how the body develops and works, and they can also influence how you respond to food, stress, or medications. More information on this topic is available in the LearnHub.
Overview
SMIM1Gene function
What if the gene works
The SMIM1 gene helps red blood cells display the Vel blood group marker on their surface. This matters for blood typing and safer transfusion matching.
Risk
What if the gene does not work
Milder variants in the SMIM1 gene may reduce the Vel marker on red blood cells, while more severe variants can remove it entirely by stopping SMIM1 protein production.
Treatment
What does that mean for your treatment
Pathogenic loss-of-function variants in both copies of the SMIM1 gene make a person Vel-negative, which mainly affects transfusion management. If anti-Vel antibodies are present, transfusions should use Vel-negative red blood cells to reduce the chance of a reaction. The SMIM1 gene does not currently guide routine medication choices.
Gene function
What if the gene works
In daily life, SMIM1 mainly matters for your red blood cells. Its protein sits in the red blood cell membrane and forms the Vel blood group antigen, a surface marker used to identify blood cells. When the SMIM1 gene works normally, this marker appears as part of the cell’s usual outer surface.
The SMIM1 gene makes a small membrane protein that carries the Vel blood group antigen on red blood cells. This surface marker helps give blood cells part of their normal blood group identity.
During red blood cell development, SMIM1 helps place this protein in the cell membrane, the thin outer layer of the cell. This gives mature red blood cells their usual Vel marker as they circulate in the bloodstream.
What is a variant?
A genetic variant is a small difference in the DNA sequence of a gene. These differences are common and help make up normal human diversity, including differences in appearance, metabolism, or how the body responds to environmental influences. Many variants do not have any noticeable effect and are simply part of natural genetic variation. In some cases, though, a variant can change how a gene functions more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the SMIM1 gene can reduce how much SMIM1 protein is made, change its shape, or stop it from reaching the red blood cell surface, which changes the Vel marker on those cells. This pattern underlies how SMIM1 gene variants affect the Vel blood group. Milder variants may leave a small amount of protein and cause weak marker expression, while more severe variants that stop the gene from working can abolish protein production and make the marker absent.
How variants are linked to conditions
Variants in the SMIM1 gene are mainly linked to the Vel-negative blood type, so SMIM1 gene variants linked to conditions are most relevant in transfusion medicine rather than in causing a disease itself. People with this blood type can form anti-Vel antibodies after exposure to Vel-positive blood, which may lead to a hemolytic transfusion reaction. In pregnancy, these antibodies have also been associated with hemolytic disease of the fetus and newborn, although this is uncommon.
A variant is not necessarily a diagnosis
Genetic variants are a routine feature of human biology and are widely found in the general population. Most do not directly affect health and instead reflect normal human diversity. For many genes, having a variant associated with a condition suggests a possible link rather than a definitive diagnosis, especially when several genes and environmental factors also play a role. In some situations, though, a single well-characterized variant in a particular gene can be enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence on specific factors that increase or reduce health risk related to the SMIM1 gene itself. In practice, SMIM1 is most relevant for blood transfusions and pregnancy blood group matching, because some people have a rare blood type linked to this gene and can react to mismatched blood.
Inheritance of SMIM1 variants
For the SMIM1 gene inheritance pattern linked to the Vel blood group, inheritance is generally autosomal codominant. You inherit one copy of the SMIM1 gene from each parent, and both copies can shape whether the Vel blood group antigen is present, absent, or weakly expressed on red blood cells. People with two altered copies are usually Vel-negative, while one altered copy often leads to weaker Vel expression. Because SMIM1 is on chromosome 1, either parent can pass a variant to a son or daughter.
What does my SMIM1 result mean for my family?
There is not yet a broadly confirmed inheritance pattern tied to a specific health condition for SMIM1. SMIM1 is best known for affecting the Vel blood group, so if you have a specific SMIM1 result and questions about what it could mean for relatives, a doctor or genetic counselor can explain it in the context of your family and any blood transfusion history.
Genetic information
Genetic testing
How you find out about variants
SMIM1 genetic testing for Vel blood type usually uses a blood or saliva sample. A lab reads the DNA to look for variants in the SMIM1 gene. This can confirm whether you carry a change linked to the Vel-negative blood type.
When should I consider getting a genetic test?
Genetic testing for the SMIM1 gene may be considered if you have a rare blood type linked to transfusion safety, especially after an unexpected reaction to a blood transfusion or when matching blood has been difficult. It can also help during pregnancy if there is concern about blood group incompatibility between parent and baby.
A genetic result is only one part of your health story
A genetic result may provide valuable information, but how much it can clarify depends on the condition and the specific type of variant. Many factors, including lifestyle, environment, age, and medical history, influence how the body functions over time. In some conditions, especially those shaped by many genes, genetic information offers context rather than certainty and is most useful when considered together with other parts of care. In other situations, a genetic result can give a clear answer. In areas like medication response, genetic results may help put personal experiences into perspective.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small differences in DNA can change how the body absorbs, breaks down, transports, or responds to a drug, so the same treatment may work better for one person and cause more side effects in another. This kind of variation is common and helps explain why medication response is not the same for everyone.
What is Pharmacogenetics?
Pharmacogenetics examines how differences in a person’s genes can affect the way they respond to medicines. It studies the relationship between genes and medications to clarify why the same treatment may work differently in different people. With many drugs, genetic factors influence both how strong the medicine’s effects are and how the body handles it. Understanding this can support treatment choices that are better informed and more individualized. More detailed information on this topic is available in the LearnHub.
Drugs influenced by the SMIM1 gene
When should I seek medical advice?
There is not currently a broadly confirmed role for this gene in how people respond to medicines, so questions about symptoms, treatment choices, or side effects are best discussed with your doctor or pharmacist.
History
For many years, doctors knew that some people lacked the Vel blood group on their red blood cells, but the genetic reason remained unclear. In recent decades, awareness of this gene’s role has grown as transfusion research advanced. In 2013, researchers identified the SMIM1 gene as the key gene behind the Vel blood group, solving a long-standing question in blood banking. This discovery mattered because people who are Vel-negative can have transfusion reactions if they receive Vel-positive blood. Building on this early work, scientists developed more accurate genetic testing to help find compatible blood for transfusion. The finding made the SMIM1 gene an important part of modern transfusion medicine.